Popular topics to explore
INFY
Infosys Q4 disappoints, net profit falls 12% YoY to Rs 7,033 cr; guidance for FY26 in single-digits
On consolidated basis
Quarter ended March 2025 compared with Quarter ended December 2024.
Net sales (including other operating income) of Infosys has declined 2.01% to Rs 40925 crore. Operating profit margin has declined from 24.22% to 24.13%, leading to 2.38% decline in operating profit to Rs 9,874.00 crore. Employee cost increased from 51.33% to 53.79%. Other expenses fell from 24.45% to 22.08%. Selling and administration expenses fell from 2.53% to 2.37%. Software technology development services cost fell from 18.94% to 17.53%.
Other income rose 38.53% to Rs 1190 crore. PBIDT rose 0.82% to Rs 11064 crore. Provision for interest rose 0.99% to Rs 102 crore. Loan funds rose to Rs 8,227.00 crore as of 31 March 2025 from Rs 8,221.00 crore as of 31 December 2024. Sundry debtors were lower at Rs 31,158.00 crore as of 31 March 2025 compared to Rs 33,358.00 crore as of 31 December 2024. Cash and bank balance rose to Rs 24,455.00 crore as of 31 March 2025 from Rs 22,804.00 crore as of 31 December 2024. Investments rose to Rs 23,541.00 crore as of 31 March 2025 from Rs 17,443.00 crore as of 31 December 2024.
PBDT rose 0.82% to Rs 10962 crore. Provision for depreciation rose 7.98% to Rs 1299 crore. Fixed assets increased to Rs 18,903.00 crore as of 31 March 2025 from Rs 18,692.00 crore as of 31 December 2024. Intangible assets declined from Rs 12,918.00 crore to Rs 12,872.00 crore.
Profit before tax down 0.07% to Rs 9,663.00 crore. Share of profit/loss were nil in both the periods. Provision for tax was expense of Rs 2625 crore, compared to Rs 2848 crore. Effective tax rate was 27.17% compared to 29.45%.
Minority interest decreased 68.75% to Rs 5.00 crore. Net profit attributable to owners of the company increased 3.34% to Rs 7,033.00 crore.
Quarter ended March 2025 compared with Quarter ended March 2024.#StockInNews#WatchOutFor#FundamentalViews#EquityResearch#PersonalFinance
107 likes·45 comments

















